Effect of vitamin E on endothelial vasodilator function in patients with hypercholesterolemia, chronic smoking or both  by Heitzer, Thomas et al.
Vascular Biology
Effect of Vitamin E on Endothelial
Vasodilator Function in Patients With
Hypercholesterolemia, Chronic Smoking or Both
Thomas Heitzer, MD,* Seppo Yla¨ Herttuala, MD,† Elke Wild,* Jukka Luoma, MD,†
Helmut Drexler, MD*
Hannover and Hamburg, Germany and Kuopio, Finland
OBJECTIVES The purpose of this study was to test the hypothesis that long-term supplementation with
Vitamin E improves endothelium-dependent relaxation in hypercholesterolemia patients
and/or chronic smoking, two risk factors that have been shown to be associated with increased
radical formation.
BACKGROUND Experimental evidence suggests that oxidized low density lipoprotein (LDL) impairs
endothelium-dependent relaxation, and vitamin E, a lipid-soluble antioxidant, reduces the
oxidation of LDL.
METHODS Thirteen subjects with hypercholesterolemia, 14 smokers and 15 hypercholesterolemic
smokers were enrolled in a double-blind, placebo-controlled study. After baseline measure-
ments of plasma autoantibodies against oxidized LDL and assessment of endothelium-
dependent relaxation using intra-arterial forearm infusions of acetylcholine, participants
within each group were randomly assigned in a 1:2 fashion to receive either placebo or vitamin
E for 4 months, when plasma levels of autoantibodies against oxidized LDL and vascular
function were reassessed.
RESULTS Vitamin E significantly augmented endothelium-dependent relaxation in hypercholester-
olemic smokers but not in patients with either hypercholesterolemia or chronic smoking. At
baseline, hypercholesterolemic smokers had significantly higher autoantibody levels against
oxidized LDL (compared with the other two groups), which were significantly reduced after
4 months of vitamin E supplementation. There was a significant relationship between
improvement in acetylcholine-induced vasodilation and the change in autoantibody titer
against oxidized LDL (r 5 20.59; p 5 0.002).
CONCLUSIONS Long-term vitamin E supplementation improves endothelium-dependent relaxation in
forearm resistance vessels of hypercholesterolemic smokers, which are characterized by
increased levels of autoantibodies against oxidized LDL. These findings may suggest that the
beneficial effect of vitamin E is confined to subjects with increased exposure to oxidized LDL.
(J Am Coll Cardiol 1999;33:499–505) © 1999 by the American College of Cardiology
The endothelium plays an integral role in the regulation of
vascular tone, platelet activity and vascular thrombosis and is
intimately involved in the pathogenesis of atherosclerosis
(1). Hypercholesterolemia and smoking are two major risk
factors for the development of atherosclerosis, and both
have been shown to be associated with impaired endothelial
function (2–4). Oxidative modification of low density li-
poprotein (LDL) cholesterol is thought to be an important
step in promoting endothelial dysfunction and ultimately
atherosclerosis (5,6). Indeed, we have recently shown a close
relationship between plasma levels of autoantibody against
oxidized LDL cholesterol and endothelium-dependent re-
laxation in human forearm circulation (3).
Antioxidants such as vitamin E have been shown to
reduce the oxidative susceptibility of lipoproteins (7–9) and
may have antiatherosclerotic effects (10). In hypercholester-
olemic animal models, vitamin E increased resistance to
lipoprotein oxidation and preserved normal endothelial
function (11,12). Epidemiologic studies also indicate an
inverse association between the intake of vitamin E and
coronary heart disease (13–15). Yet the data from clinical
trials concerning the beneficial effect of vitamin E supple-
ments in protecting from coronary artery disease and car-
diovascular mortality have been inconsistent. Whereas some
trials found no effect on mortality from cardiovascular
disease among those receiving 50 mg of vitamin E (15,16),
another trial has suggested a reduction in the incidence of
nonfatal myocardial infarction with larger doses of supple-
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ments (17). Conceivably, vitamin E may not prevent car-
diovascular disease and ischemic events in the general
population but rather in susceptible individuals, that is,
those with limited or impaired defense mechanisms against
oxidative stress such as hypercholesterolemic patients (18)
and/or chronic smokers (19). Since endothelial dysfunction
may represent an early step in the development of cardio-
vascular disease and trigger ischemic events, the present trial
was designed to investigate the effect of vitamin E supple-
mentation on endothelium-dependent vasodilation and
LDL oxidation in subjects with hypercholesterolemia
and/or chronic smoking.
METHODS
Subjects and study design. Subjects were eligible for the
treatment trial if they had a serum LDL cholesterol level,
measured after a 12-h fasting period, of more than the 75th
percentile for age and gender and were not receiving
cholesterol-lowering medication (lowest cutoff 155 mg%).
An age-matched group of normal individuals (control
group) without risk factors was assessed for endothelial
function and LDL values for comparison but was not
enrolled in the long-term treatment protocol. Long-term
smokers were included if they had a history of .20
pack-years (1 pack-year defined as smoking 20 cigarettes per
day for 1 year or the equivalent). No participant had a
history of diabetes mellitus, arterial hypertension, heart
failure or any other systemic disease predisposing them to
endothelial dysfunction. Nonsmokers were not exposed to
smoking at their homes, leisure or work and therefore,
exposure to environmental tobacco smoke was minimal or
absent. Further exclusion criteria were current use of anti-
oxidants or vasoactive medication.
After an initial screening period to confirm eligibility
requirements, 42 subjects were included in this prospective,
randomized, double-blind, placebo-controlled study: 13
subjects with hypercholesterolemia, 14 long-term smokers
and 15 hypercholesterolemic subjects who smoked. Partic-
ipants within each group were randomly assigned in a 1:2
fashion to receive either placebo or vitamin E in order to
treat approximately one third of each group with placebo
and the other two thirds of each group with vitamin E. This
randomization procedure was used to minimize studies in
patients on placebo. After the initial study of vascular
function, the subjects received either placebo or vitamin E
(d-alpha-tocopherol acetate 544 IU per day) for four
months. The hypercholesterolemic subjects received a di-
etary counseling but no lipid-lowering medication. At the
four-month follow-up serum lipid concentrations and vas-
cular function were measured using the same protocol. This
study was approved by the Ethics Committee of the
University of Freiburg, and each subject gave written in-
formed consent.
Vascular function studies. Studies took place in a 23°C
temperature-controlled laboratory in the postprandial state.
Under local anesthesia and sterile conditions, a 20-gauge
polyethylene catheter was inserted into the brachial artery of
the nondominant arm for infusion of drugs. Forearm blood
flow was measured by venous occlusion plethysmography as
recently described (3). Systolic, diastolic and mean arterial
pressures and heart rate were determined at the contralateral
arm with a Dinamap recorder.
Baseline measurements of forearm blood flow were ob-
tained during intra-arterial infusion of 0.9% saline at a rate
of 1.66 ml/min. To assess endothelium-dependent vasodi-
lation, acetylcholine chloride was administered at increasing
concentrations (7.5, 15, 30 and 60 mg/min). Then, sodium
nitroprusside was infused as an endothelium-independent
vasodilator (1, 3 and 10 mg/min). Each dose of drug was
infused for five min, with measurements of forearm blood
flow being made over the final two min of each infusion
period.
Measurement of autoantibody against oxidized LDL.
Blood samples were obtained after a 12-h fasting period on
the same day as the flow measurements. Serum was sepa-
rated from blood elements by centrifugation, and aliquots
were stored at 280°C. Immunoglobulin G autoantibodies
against copper-oxidized LDL were measured in a subset of
patients as previously described (3). All measurements were
done in duplicate without knowledge of the forearm blood
flow measurements and were performed in a single assay
(S.Y.H. and J.L.). Results were expressed as ratio of
oxidized LDL to native LDL at 1:50 dilution.
Statistical analysis. All data are expressed as mean 6
SEM. Statistical analysis was performed by analysis of
variance for repeated measurements followed by Tukey’s
Studentized Range Test. Associations between the effects of
vitamin E and clinical parameters were examined by regres-
sion analysis.
RESULTS
Patient characteristics. The treatment study population
consisted of 42 subjects. Baseline characteristics and lipid
profiles of subjects are shown in Table 1. Total cholesterol
and LDL cholesterol plasma levels were lower in chronic
smokers by definition as compared to hypercholesterolemic
subjects. There were no differences in HDL cholesterol and
triglyceride levels between the groups. The lipid measure-
ments at follow-up showed no significant changes in any of
the groups. A normal control (nonsmoking) group (n 5 10)
was studied in the same manner and had normal cholesterol,
LDL and high density lipoprotein levels.
Abbreviations and Acronyms
LDL 5 low density lipoprotein
NO 5 nitric oxide
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Forearm vasomotor function. Intra-arterial infusion of
acetylcholine caused a dose-dependent and significant in-
crease in forearm blood flow in all groups. The acetylcholine-
induced increase in forearm blood flow was significantly
impaired in all three treatment groups (hypercholesterolemia,
smoking, both risk factors) as compared to the age-matched
control group (p , 0.05). In the control group, acetylcholine
(7.5, 15, 30, 60 mg/min) increased forearm blood flow from
3.0 6 0.3 to 7.1 6 0.5, 10.6 6 0.8, 17.0 6 0.6 and 21.9 6 0.7
ml/min/100 g. Sodium nitroprusside (1, 3, 10 mg/min) in-
creased forearm blood flow from 3.1 6 0.2 to 7.1 6 0.3,
11.1 6 0.8 and 14.9 6 0.5 ml/min/100 g.
Vitamin E treatment did not affect the acetylcholine-
induced increase in forearm blood flow in hypercholester-
olemic patients (Fig. 1). In chronic smokers, vitamin E
therapy tended to cause a mild augmentation in blood flow
(Fig. 1), but the study did not have enough power to detect
a significant difference. However, in hypercholesterolemic
smokers (Fig. 1), the maximal flow in response to acetyl-
choline increased from 7.8 6 2.4 ml/min/100 ml at baseline
Figure 1. Mean (6SEM) responses of forearm blood flow to intra-arterial acetylcholine in hypercholesterolemic subjects (left panel),
chronic smokers (middle panel) and hypercholesterolemic smokers (right panel) at baseline and after 4 months of treatment with either
placebo or vitamin E. Vitamin E therapy improved the acetylcholine-induced increase in forearm blood flow (reflecting endothelium-
dependent vasodilation) only in hypercholesterolemic smokers (*p , 0.01 as compared to the corresponding placebo group).
Table 1. Characteristics and Lipid Profiles of Study Groups
Hypercholesterolemia Chronic Smoking
Hypercholesterolemia
and Smoking
Vitamin E
(n 5 90)
Placebo
(n 5 4)
Vitamin E
(n 5 10)
Placebo
(n 5 4)
Vitamin E
(n 5 10)
Placebo
(n 5 5)
Gender (men/women) 9/0 4/0 9/1 4/0 9/1 5/0
Age (yr) 56 53 55 54 53 52
MAP (mm Hg) 92 94 93 92 94 93
Cholesterol (mg/dl)
Baseline 298 6 13 287 6 9 211 6 10* 212 6 11* 276 6 13 274 6 8
Follow-up 292 6 15 268 6 10 209 6 12* 217 6 13* 273 6 14 270 6 7
LDL cholesterol (mg/dl)
Baseline 221 6 16 216 6 5 139 6 8* 155 6 6* 209 6 14 195 6 12
Follow-up 211 6 7 194 6 5 134 6 11* 153 6 5* 195 6 15 189 6 13
HDL cholesterol (mg/dl)
Baseline 44 6 3 42 6 2 43 6 3 42 6 3 46 6 4 42 6 4
*p , 0.05 versus hypercholesterolemia, and smoking and hypercholesterolemia. Values are given as mean 6 SEM.
HDL 5 high density lipoprotein; LDL 5 low density lipoprotein; MAP 5 mean arterial pressure.
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to 15.7 6 3.2 ml/min/100 ml after 4 months of vitamin E.
This difference between the acetylcholine-induced vasodi-
lator response at baseline and that at follow-up was statis-
tically significant (p , 0.003).
Infusion of sodium nitroprusside increased forearm blood
flow in all groups. There was no significant change between
baseline and follow-up in any of the groups (data not
shown).
Autoantibody titer against oxidized LDL. Autoantibody
levels against oxidized LDL averaged 1.12 6 0.16 in the
control group and were not significantly increased in the
group with hypercholesterolemia or chronic smoking. How-
ever, hypercholesterolemic smokers had significantly higher
autoantibody titer levels against oxidized LDL compared
with the other groups (p , 0.03; Fig. 2). The elevated
autoantibody titer level was reduced after 4 months of
vitamin E supplementation and did not differ from the other
two groups at follow-up. Vitamin E did not affect the
autoantibody titer of oxidized LDL in the smoking and the
hypercholesterolemic group. Autoantibody titer against ox-
idized LDL did not change in placebo-treated patients,
indicating that storage of plasma did not affect autoantibody
levels.
Relation between autoantibody titer against oxidized
LDL and changes in endothelial function. There was a
significant relationship between improvement in
acetylcholine-induced vasodilation and autoantibody titer
against oxidized LDL at baseline (r 5 0.50; r 5 0.013).
Patients with a higher degree of autoantibodies against
oxidized LDL at baseline were more likely to have improve-
ment by vitamin E supplementation. Furthermore, the
change in autoantibody titer against oxidized LDL corre-
lated significantly with the change in endothelial function
(r 5 20.59; p 5 0.002; Fig. 3).
DISCUSSION
Both hypercholesterolemia and chronic smoking have been
shown to impair endothelial vasodilator function in humans
(2– 4). These risk factors synergistically reduce
endothelium-dependent relaxation, and their combined
presence is associated with increased plasma levels of auto-
antibodies against oxidized LDL (3). Similar to these
previous observations, endothelial vasodilator function was
impaired in patients with hypercholesterolemia or chronic
smoking (as compared to age-matched normal individuals
[3]); however, the most severe impairment of endothelium-
dependent relaxation was noted in patients with both risk
factors, confirming our previous finding. Moreover, the
combined presence of chronic smoking and hypercholester-
olemia was associated with increased levels of autoantibod-
ies against oxidized LDL. The present study demonstrated
a beneficial effect of vitamin E supplementation on endo-
thelial vasodilator dysfunction selectively in hypercholester-
olemic smokers, and this effect on vascular function was
associated with a reduction of the elevated autoantibody
titers against oxidized LDL in these patients.
Potential mechanisms. The endothelium is an important
modulator of vasomotor tone through the release of
endothelium-derived relaxing factors such as nitric oxide.
Impairment of the endothelium-dependent release of nitric
oxide (NO) has been demonstrated in patients with risk
factors for atherosclerosis including hypercholesterolemia
and chronic smoking (2–4). The underlying mechanisms
are not clearly identified, but increased vascular production
of superoxide anion has been implicated as contributing to
impaired endothelium-dependent vascular relaxation in an-
imal models of hypercholesterolemia (20). In fact, there is
some evidence that LDL uncouples L-arginine metabolism
Figure 2. Mean (6SEM) levels of autoantibody titer against
oxidized (ox) low density lipoprotein (LDL) in hypercholester-
olemic subjects, long-term smokers and subjects with hypercho-
lesterolemia who smoked (n 5 8 for each group) at baseline and
after 4 months of treatment with vitamin E. *p , 0.05 versus other
baseline values and versus values after vitamin E therapy. nat 5
natural.
Figure 3. Relation between change (delta 5 value at 4 months
minus value at baseline) in autoantibody titer against oxidized
LDL and change in maximal acetylcholine-induced vasodilation.
ACh 5 acetylcholine. Other abbreviations as in Figure 2.
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from NO release to increase production of superoxide
anions by endothelial NO synthase (21), supporting the
concept in concert with other studies (22) that a dysfunc-
tional endothelial NO synthase represents one source of
reactive oxygen metabolites.
Recent evidence also suggests that increased degradation
of NO by oxygen-derived free radicals may be an important
mechanism for endothelial dysfunction in chronic smoking
(23,24). In addition, reactive oxygen species may promote
oxidative modification of LDL within the vascular wall,
which is thought to be a key process in the development of
endothelial dysfunction and atherosclerosis (5,6).
We have recently shown that cigarette smoking potenti-
ates endothelial dysfunction of forearm resistance vessels in
subjects with hypercholesterolemia, possibly due to en-
hanced oxidation of LDL (3) as suggested by a close inverse
relationship between plasma levels of autoantibody titer to
oxidized LDL and acetylcholine-induced blood flow re-
sponses.
In the present study we tested the hypothesis that this
study population benefits from antioxidant therapy. There
are several important differences between the naturally
occurring antioxidants ascorbic acid, vitamin E and beta-
carotene. Whereas ascorbic acid is water-soluble and is able
to scavenge superoxide anion directly, the primary antioxi-
dant effects of vitamin E may be related to its ability to
scavenge lipid peroxyl radicals and thus inhibit lipid peroxi-
dation in LDL and cell membranes of the vascular wall.
Incubation of LDL with alpha-tocopherol inhibits
copper- and endothelial cell–mediated modification of LDL
(25), and supplementation of healthy subjects with pharma-
cologic doses of vitamin E increases the resistance of LDL
to oxidation ex vivo (7–9). There is evidence that circulating
products of lipid peroxidation are increased in smokers (26)
and that indices of sustained oxidant stress in smokers are
partially ameliorated by vitamin E supplementation (27,28).
In the present study, autoantibody titer against oxidized
LDL was measured with LDL oxidized with copper for
24 h as the antigen. As discussed previously, this autoanti-
body titer is not confined to properties of circulating LDL,
but may rather reflect the immune response to both plasma
and vascular wall levels of oxidized LDL (3). Subjects with
hypercholesterolemia and smoking had markedly increased
autoantibody titers against oxidized LDL and showed the
most attenuated endothelium-dependent vasodilation.
The increased level of autoantibody against oxidized
LDL was substantially reduced by vitamin E supplementa-
tion (along with improvement of endothelial function),
whereas autoantibody titers in the normal range of hyper-
cholesterolemic subjects and of chronic smokers were not
affected by vitamin E. Thus, it appears that vitamin E may
selectively be effective in a subgroup of patients, that is,
individuals with elevated levels of autoantibodies against
oxidized LDL. Our findings are consistent with previous
clinical observations. Large-scale trials did not detect a
beneficial effect of vitamin E in unselected individuals (16),
whereas vitamin E significantly reduced coronary morbidity
in patients with myocardial infarction (17), possibly a subset
of individuals with increased exposure to oxidized LDL.
Comparison with previous studies. Importantly, the
failure of vitamin E in the present study to improve
endothelium-dependent relaxation in patients with hyper-
cholesterolemia is consistent with previous reports (29,30).
Notably, the beneficial effect of vitamin E in the present
study was confined to hypercholesterolemic chronic smokers
with severely impaired endothelium-dependent relaxation
and elevated antibody titers against oxidized LDL. In fact,
the beneficial effect of vitamin E on endothelial function
was correlated to the degree of autoantibody titer against
oxidized LDL at baseline. Thus subjects with higher levels
of oxidized LDL autoantibodies were more likely to benefit
from vitamin E supplementation. Furthermore, the degree
of improvement with vitamin E was related to the degree of
reduction in autoantibodies against oxidized LDL. These
observations are consistent with the notion that smoking
may increase lipid peroxidation in hypercholesterolemia and
increase the damage of endothelial function. Therefore,
hypercholesterolemic smokers may particularly benefit from
antioxidative supplementation with vitamin E. Our findings
are in keeping with recent animal studies demonstrating
that vitamin E preserves normal endothelium-dependent
arterial relaxation in experimental hypercholesterolemia and
atherosclerosis (11,12). The precise mechanism responsible
for this effect is not clear, but preservation of vascular
reactivity by preventing LDL oxidation or a more direct
vascular effect by tissue incorporation of alpha-tocopherol
may play a role (31).
Limitations of the study. It should be noted that similar
doses of vitamin E as used in the present study have been
shown to affect diene lag time (7,8), suggesting that the
beneficial effect of vitamin E is due to reduced oxidation of
LDL (assuming that the decrease in the levels of autoanti-
bodies against oxidized LDL reflect reduced exposure to
oxidized LDL). However, the present study cannot defi-
nitely prove that the beneficial effect of vitamin E on
endothelial vasodilator function is attributed to the reduc-
tion of autoantibodies against oxidized LDL. There is
experimental evidence that NO can prevent LDL oxidation
by endothelial cells (32). Thus, the reduced levels of
autoantibodies against LDL may be secondary to increased
availability of endothelium-derived NO. Furthermore, im-
provement of endothelial vasodilator function may be at-
tributed to increased release of prostaglandin from the
endothelium, endothelium-derived hyperpolarizing factor
or a reduced production of a vasoconstrictor prostanoid.
Notably, patients with either hypercholesterolemia or
chronic smoking had impaired endothelium-dependent re-
laxation, which was not affected by vitamin E treatment.
The selective beneficial effect of vitamin E in patients with
both risk factors and increased levels of autoantibodies
against LDL suggests that only the synergistic adverse effect
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of these risk factors on endothelial vasodilator function is
prevented by vitamin E, consistent with recent observations
in hypercholesterolemic rabbits exposed to tobacco smoke
(33). Notably, a small improvement in endothelial function
was observed in smokers; however, our study did not have
enough power to conclude that this difference was signifi-
cant.
Autoantibody levels were not measured in all patients due
to technical reasons. However, the patients without these
measurements did not differ in clinical characteristics or
endothelial function tests from those individuals with auto-
antibody measurements. Moreover, treatment effects were
observed with vitamin E but not placebo and were related to
the baseline values, indicating a true treatment effect of
vitamin E.
In conclusion, the present study demonstrates that vita-
min E supplementation improves endothelial vasomotor
function in subjects with increased autoantibody titer
against oxidized LDL. The beneficial effect of vitamin E
selectively in these “high risk” patients may represent one
explanation for the failure of recent large-scale trials to
demonstrate a preventive effect of vitamin E in the general
population.
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